# Artiva Biotherapeutics Inc. (ARTV) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $11.19, market value $547 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Artiva Biotherapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 1.6×**. The shares trade at 1.6× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -14.1%** (5-yr avg -62.4%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -76.3%**. Return on equity is negative because earnings are negative.
- **Return on assets: -64.0%**. Each dollar of assets produces -64.0% of profit.

## Growth
- **Revenue growth (1 yr): -100.0%**. Revenue fell 100.0% over the last year.
- **EPS growth (1 yr): 41.0%**. Earnings per share rose 41.0%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 8.61** (quick 8.61). Current assets cover the next year's liabilities 8.61 times.
- **Altman Z-score: 15.48**. A Z-score of 15.48 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Artiva Biotherapeutics Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 259.8%** (YTD 160.8%, 3-mo 63.4%). The shares are up 259.8% over twelve months including dividends.
- **From 52-week high: -23.0%** (404.1% above the low). Trading 23% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 51**. An RSI of 51 is neutral.
- **Beta (1 yr): 2.01** (volatility 184%). Beta of 2.01 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ARTV · Page: https://foliofundamentals.com/stocks/artv

Not investment advice.